Sector Gilead Sciences, Inc.

Aandelen

GILD

US3755581036

Farmaceutische producten

Beurs gesloten - 22:00:00 19-10-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
153,07 USD -2,00% Intraday-grafiek van Gilead Sciences, Inc. +1,75% +24,71%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
-2,00%+1,75%+1,67%+14,91%+24,71%+24,34%+95,14%+128,80%+108,71% 194 mld.
-1,33%+4,88%+6,48%+8,15%+15,41%+53,33%+109,94%+411,88%+1.478,84% 1.120 mld.
-0,69%-3,77%-5,82%+2,00%+22,63%+31,01%+66,62%+54,87%+121,48% 616 mld.
-0,96%+0,55%+6,88%+11,56%+23,72%+21,81%+94,26%+163,08%+360,17% 504 mld.
+0,24%+6,23%+6,53%+13,73%+15,81%+33,98%+52,38%+4,44%+62,71% 367 mld.
-1,59%-1,25%-3,93%+15,46%+36,45%+66,39%+43,02%+80,69%+132,15% 360 mld.
-0,40%+4,28%+7,91%-0,64%+13,32%+19,17%+42,51%+62,74%+65,27% 288 mld.
-0,37%+3,35%-0,80%-1,54%-10,08%-1,26%+16,85%+42,55%+147,90% 258 mld.
-1,75%+1,76%+8,08%+16,69%+29,83%+40,09%+51,44%+105,50%+163,81% 234 mld.
-1,19%+0,49%-8,90%-22,25%-21,14%-25,14%-64,02%-23,11%+86,34% 173 mld.
-0,47%+3,66%+6,13%+18,95%+18,23%+19,24%-5,61%-30,05%-9,69% 169 mld.
+0,44%-1,00%-1,72%+4,46%+10,72%+19,77%+37,60%+170,72%+513,41% 127 mld.
-1,54%+2,17%-6,05%-2,21%+9,07%+34,96%+4,16%+2,15%+17,97% 122 mld.
+0,56%+5,72%+13,98%+21,52%+23,18%+28,26%+122,92%+398,76%+527,13% 117 mld.
-0,40%+6,00%-1,20%-3,21%+1,67%+14,15%+24,05%+6,33%-10,98% 99,56 mld.
-1,29%-0,71%-4,11%-8,18%-14,16%-17,84%-29,94%-14,09%+3,12% 96,96 mld.
+4,07%+6,15%+31,20%+281,39%+669,38%+732,93%+175,45%-31,99% - 87,04 mld.
-1,10%+2,52%-2,02%+16,35%+1,32%+35,59%-3,29%+41,65%+112,30% 78,96 mld.
+0,03%+4,72%+11,17%+5,91%+17,74%+28,65%-0,82%-25,25%+45,96% 70,58 mld.
-0,30%+5,23%-6,11%-13,53%-23,16%-7,95%+35,89%+61,50%+430,04% 66,2 mld.
Gemiddelde -0,18%+3,11%+2,97%+18,98%+43,23%+57,57%+43,43%+80,56%+229,30% 257,37 mld.
Gewogen gemiddelde per kap. -0,35%+3,35%+2,92%+11,53%+26,53%+43,18%+61,78%+145,40%+451,02%
  1. Beurs
  2. Aandelen
  3. Koers GILD
  4. Sector Gilead Sciences, Inc.